Food and Drug Administration
Pharma

Regulatory tracker: GSK's Blenrep gets all clear in NICE guidance

Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Graphic image of puzzle pieces missing from a persons brain a symbol of degeneration andor the improvement of it

Anti-amyloid Alzheimer's drugs show 'trivial' effects: report

Apr 16, 2026 11:36am
Roche

Roche to launch another Elevidys study, eying EU approval

Apr 16, 2026 10:06am
Eli Lilly Lilly

Lilly answers FDA's call for more Foundayo safety information

Apr 16, 2026 9:43am
Olixir rebrand

Omnicom brews Olixir from FCB Health, rebranding storied agency

Apr 16, 2026 8:01am
An artists concept of chains of amino acides called peptides which together make up polypeptides or proteins

FDA advisory committee to discuss action on unapproved peptides

Apr 15, 2026 5:15pm
More News

Daiichi Sankyo plots $1.5B consumer health unit sale to Suntory

Apr 15, 2026 3:22pm

MSF decries Gilead's updated global access plan for Yeztugo

Apr 15, 2026 12:14pm

Novartis CEO Vas Narasimhan joins Anthropic's board

Apr 15, 2026 10:36am

Astellas manufacturing chief talks strategy 1 year into role

Apr 15, 2026 10:35am